Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
BLUEJET
₹575.75
₹564.20
₹587.00
₹325.00
₹1027.80
Markets Today
Historical Performance
As of 09-07-2026 17:17, Blue Jet Healthcare Ltd share price today is ₹0, with a change of ₹-562.70 (-100.00%) from the previous close of ₹562.7. The stock opened at ₹568 and traded between ₹564.2 and ₹587, with a total traded volume of 546527 shares. The company has a market capitalization of ₹10046.2 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1027.8 and ₹325, respectively.
Blue Jet Healthcare Ltd valuation metrics include a P/E ratio of 40.5, and book value of ₹7.40. Profitability indicators show ROE of 18.22% along with a dividend yield of 0.2%. Blue Jet Healthcare Ltd has reported revenue of ₹947.32 Cr and net profit of ₹247.82 Cr.
Blue Jet Healthcare Ltd technical indicators include Day RSI at 71.72, Day MFI at 81.45, Day ADX at 47.3. Additional indicators include Commodity Channel Index (CCI) at 170.7 and Williams %R at -8.65. Momentum indicators show Day MACD at 26.19, Day MACD Signal Line at 21.92, DayATR at 24.03. Rate of Change indicators for Blue Jet Healthcare Ltd include ROC125 at 9.23 and ROC21 at 24.51.
Exponential moving averages include EMA5 at ₹561.1, EMA10 at ₹546.3, EMA12 at ₹541.4, EMA20 at ₹525.1, EMA26 at ₹515.2, EMA50 at ₹487.9, EMA100 at ₹476.2, EMA200 at ₹510.9. Simple moving averages include SMA5 at ₹562.9, SMA10 at ₹541.5, SMA20 at ₹521.4, SMA30 at ₹502.2, SMA50 at ₹481.9, SMA100 at ₹432.9, SMA150 at ₹457.4, SMA200 at ₹502.8.
Support levels for Blue Jet Healthcare are placed at First Support ₹561.33, Second Support ₹543.52, Third Support ₹531.03. Resistance levels are seen at First Resistance ₹591.63, Second Resistance ₹604.12, Third Resistance ₹621.93. Blue Jet Healthcare Ltd shareholding pattern shows promoter holding at 79.81%, FII holding at 0.4%, DII holding at 0%, public holding at 15.14%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 234.67 | 192.41 | 165.48 | 354.76 | 340.44 |
| Operating Expense | 163.40 | 145.52 | 110.53 | 233.76 | 200.48 |
| Operating Profit | 71.27 | 46.89 | 54.95 | 120.99 | 139.97 |
| Depreciation | 6.46 | 5.98 | 5.87 | 5.70 | 4.95 |
| Interest | 0.58 | 0.34 | 4.63 | 0.69 | 0.03 |
| Tax | 22.80 | 13.61 | 16.59 | 31.69 | 37.12 |
| Net Profit | 64.34 | 40.17 | 52.14 | 91.17 | 110.10 |
₹575.75
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 86 | 86 | 79.8 | 79.8 | 79.8 | 79.8 |
| FII | 2.3 | 2 | 1.8 | 1.1 | 0.9 | 0.4 |
| DII | 1.3 | 0.9 | 3.7 | 4.7 | 4.5 | 4.6 |
| Public | 10.4 | 11.1 | 14.7 | 14.4 | 14.8 | 15.1 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 7.88 L | 28.99 L | 27.17% |
| Week | 4.68 L | 13.11 L | 35.71% |
| 1 Month | 3.26 L | 10.48 L | 31.06% |
| 6 Month | 2.85 L | 7.97 L | 35.78% |
Companies with no Debt
Benjamin Graham Value Screen
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Expensive Performers (DVM)
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing Revenue every quarter for the past 2 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stock gained more than 20% in one month
RSI indicating price strength
High Volume, High Gain
Top Gainers
High Volume, High Gain
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Sep, 2025 | 1.2 | FINAL | 19 Sep, 2025 | Equity Share |
| 18 Sep, 2024 | 1 | FINAL | 18 Sep, 2024 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹2,027.20 | ₹807 | ₹1,418.10 | ₹1,625 | ₹4,508 | ₹660 |
| % Change | 2.41% | 0.84% | 0.59% | 0.81% | -0.69% | 1.95% |
| Revenue TTM (₹ Cr) | ₹1,403.18 | ₹642.26 | ₹649.50 | ₹1,421.59 | ₹935 | ₹4,359.02 |
| Net Profit TTM (₹ Cr) | ₹185.12 | ₹172.89 | ₹115.38 | ₹-73.80 | ₹257.90 | ₹255.19 |
| PE TTM | 65.70 | 53.00 | 54.20 | -252.70 | 41.10 | 40.10 |
| 1 Year Return | 87.27 | 36.75 | 136.79 | -18.59 | -14.34 | 14.03 |
| ROCE | 31.54 | 24.22 | 15.60 | 0.59 | - | 11.40 |
Innova Captab Ltd.
₹ 992.00
+0.93%
Concord Biotech Ltd.
₹ 1311.20
+4.08%
Aarti Pharmalabs Ltd.
₹ 704.00
+2.59%
Supriya Lifescience Ltd.
₹ 876.50
+1.72%
Alivus Life Sciences Ltd.
₹ 1145.90
+1.40%
Cohance Lifesciences Ltd.
₹ 441.00
+2.37%
Eris Lifesciences Ltd.
₹ 1430.00
+0.99%
Syngene International Ltd.
₹ 415.85
+1.03%
Alembic Pharmaceuticals Ltd.
₹ 816.00
+0.58%
Sun Pharma Advanced Research Company Ltd.
₹ 278.05
+2.99%
Strides Pharma Science Ltd.
₹ 1072.00
-0.81%
FDC Ltd.
₹ 431.70
+1.96%
Shilpa Medicare Ltd.
₹ 624.80
+4.95%
Jubilant Pharmova Ltd.
₹ 972.00
+0.13%
Natco Pharma Ltd.
₹ 961.55
-0.49%
Caplin Point Laboratories Ltd.
₹ 2626.00
+3.86%
Marksans Pharma Ltd.
₹ 278.80
+5.83%
Orchid Pharma Ltd.
₹ 1050.00
+4.76%
Bliss GVS Pharma Ltd.
₹ 526.90
+2.72%
Sanofi India Ltd.
₹ 3349.00
-0.96%
Procter & Gamble Health Ltd.
₹ 6600.00
+5.39%
Jeena Sikho Lifecare Ltd.
₹ 590.00
+4.71%
By signing up I certify terms, conditions & privacy policy